-
between HIV-1 resistance to the recently approved capsid inhibitor Lenacapavir (Sunlenca/Yeztugo), viral fitness, and capsid/host factor interactions. Applicants with strong backgrounds in molecular biology
-
, their molecular movements, and their interaction with other proteins within the cell membrane. We propose that understanding of single molecular movements will allow us to gain further insight in the receptor
Searches related to interactive
Enter an email to receive alerts for interactive positions